Hypusine formation on the eukaryotic
initiation factor 5A (eIF-5A) precursor represents a unique posttranslational modification that is ubiquitously present in eukaryotic cells and archaebacteria. Specific inhibition of
deoxyhypusine synthase leads to growth arrest and cell death. The precise cellular function of
eIF-5A and the physiological significance of
hypusine modification are not clear. Although the methionyl-
puromycin synthesis has been suggested to be the functional assay for
eIF-5A activity in vitro, the role of
eIF-5A in
protein synthesis has not been established. Recent studies have suggested that
eIF-5A may be the cellular target of the human immunodeficiency virus type 1 Rev and human
T cell leukemia virus type 1 Rex
proteins. Motif analysis suggested that
eIF-5A resembles a bimodular
RNA-binding protein in that it contains a stretch of
basic amino acids clustered at the N-terminal region and a
leucine-rich stretch at the C-terminal region. Using Rev target
RNA, RRE, as a model, we tested the hypothesis that
eIF-5A may be an
RNA-binding protein. We found that both
deoxyhypusine and
hypusine-containing
eIF-5A can bind to the 252-nt RRE
RNA, as determined by a gel mobility shift assay. In contrast, the unmodified
eIF-5A precursor cannot.
Deoxyhypusine-containing
eIF-5A, but not its precursor, could also cause supershift of the Rev stem-loop IIB RRE complex. Preliminary studies also indicated that
eIF-5A can bind to
RNA such as
U6 snRNA and that
deoxyhypusine modification appears to be required for the binding. The ability of
eIF-5A to directly interact with
RNA suggests that
deoxyhypusine formation of
eIF-5A may be related to its role in RNA processing and
protein synthesis. Our study also suggests the possibility of using a gel mobility shift assay for eIF-5A-RNA binding as a functional assay for
deoxyhypusine and
hypusine formation.